The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Conversion of Acetaminophen to the Bioactive N-Acylphenolamine AM404 via Fatty Acid Amide Hydrolase-dependent Arachidonic Acid Conjugation in the Nervous System
Open accessAbstract
Acetaminophen (paracetamol) is a popular domestic analgesic and antipyretic agent with a weak anti-inflammatory action and a low incidence of adverse effects as compared with aspirin and other non-steroidal anti-inflammatory drugs. Here we show that acetaminophen, following deacetylation to its primary amine, is conjugated with arachidonic acid in the brain and the spinal cord to form the potent TRPV1 agonist N-arachidonoylphenolamine (AM404). This conjugation is absent in mice lacking the enzyme fatty acid amide hydrolase. AM404 also inhibits purified cyclooxygenase (COX)-1 and COX-2 and prostaglandin synthesis in lipopolysaccharide-stimulated RAW264.7 macrophages. This novel metabolite of acetaminophen also acts on the endogenous cannabinoid system, which, together with TRPV1 and COX, is present in the pain and thermoregulatory pathways. These findings identify fatty acid conjugation as a novel pathway for drug metabolism and provide a molecular mechanism for the occurrence of the analgesic N-acylphenolamine AM404 in the nervous system following treatment with acetaminophen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“moreover, it inhibits cyclooxygenases in the brain, albeit at concentrations that are probably not attainable with analgesic doses of paracetamol.”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [102]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“However, the actual contribution of these activities of AM404 to the analgesic effect of paracetamol seems negligible.”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [102]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the analgesic effect of paracetamol is due to the indirect activation of cannabinoid CB 1 receptors”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [102]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This novel metabolic pathway (fatty acid conjugation) is of crucial functional importance because it generates the active metabolite of paracetamol.It is negligible, however, in the overall biotrasformation of the drug.”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [102]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At this concentration AM404 activates both rat (102,235) and human (66) TRPV1 receptors, while significant COX-1 and COX-2 inhibition and prostaglandin E 2 formation reduction are obtained at micromolar concentrations (102).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [102]
Experimental — accuracy not yet measured
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
The formalin test in mice: dissociation between inflammatory and non-inflammatory pain
Hunskaar, S., & Hole, K. (1987) · Pain · doi:10.1016/0304-3959(87)90088-1 · Cited by 2,186
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Self-citationMolecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Self-citationVanilloid (Capsaicin) Receptors and Mechanisms
Szallasi, A., & Blumberg, P. M. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01403-0 · Cited by 1,903
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310
Self-citationHuang, S. M., Bisogno, T., Trevisani, M., Al-Hayani, A., De Petrocellis, L., Fezza, F., Tognetto, M., Petros, T. J., Krey, J. F., Chu, C. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122196999 · Cited by 964
Mezey, É., Tóth, Z. E., Cortright, D. N., Arzubi, M. K., Krause, J. E., Elde, R., Guo, A., Blumberg, P. M., & Szallasi, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3655 · Cited by 850
Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813
FLOWER, R. J., & VANE, J. R. (1972) · Nature · doi:10.1038/240410a0 · Cited by 779
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
Deutsch, D. G., & Chin, S. A. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90486-g · Cited by 702
The endocannabinoid system as a target for therapeutic drugs
Piomelli, D., Giuffrida, A., Calignano, A., & Rodrı́guez de Fonseca, F. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01482-6 · Cited by 421
BISOGNO, T., MELCK, D., BOBROV, M. Y., GRETSKAYA, N. M., BEZUGLOV, V. V., De PETROCELLIS, L., & Di MARZO, V. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510817 · Cited by 381
Central and peripheral antialgesic action of aspirin-like drugs
Ferreira, S. H., Lorenzetti, B. B., & Corrêa, F. M. A. (1978) · European Journal of Pharmacology · doi:10.1016/0014-2999(78)90265-0 · Cited by 368
De Petrocellis, L., Bisogno, T., Davis, J. B., Pertwee, R. G., & Di Marzo, V. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02082-2 · Cited by 347
Egertová, M., Cravatt, B. F., & Elphick, M. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00145-3 · Cited by 347
Self-citationDeletion of vanilloid receptor 1_expressing primary afferent neurons for pain control
Karai, L., Brown, D. C., Mannes, A. J., Connelly, S. T., Brown, J., Gandal, M., Wellisch, O. M., Neubert, J. K., Olah, Z., & Iadarola, M. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20449 · Cited by 340
Huang, S. M., Bisogno, T., Petros, T. J., Chang, S. Y., Zavitsanos, P. A., Zipkin, R. E., Sivakumar, R., Coop, A., Maeda, D. Y., De Petrocellis, L., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107351200 · Cited by 339
The anandamide transport inhibitor AM404 activates vanilloid receptors
Zygmunt, P. M., Chuang, H.-H., Movahed, P., Julius, D., & Högestätt, E. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00207-7 · Cited by 270
Self-citationStructural determinants for recognition and translocation by the anandamide transporter
Piomelli, D., Beltramo, M., Glasnapp, S., Lin, S. Y., Goutopoulos, A., Xie, X.-Q., & Makriyannis, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5802 · Cited by 268
Pomonis, J. D., Harrison, J. E., Mark, L., Bristol, D. R., Valenzano, K. J., & Walker, K. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046268 · Cited by 260
Iodo-Resiniferatoxin, a New Potent Vanilloid Receptor Antagonist
Wahl, P., Foged, C., Tullin, S., & Thomsen, C. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12350-4 · Cited by 260
Kalgutkar, A. S., Crews, B. C., Rowlinson, S. W., Marnett, A. B., Kozak, K. R., Remmel, R. P., & Marnett, L. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.925 · Cited by 252
Clissold, S. P. (1986) · Drugs · doi:10.2165/00003495-198600324-00005 · Cited by 244
Fegley, D., Kathuria, S., Mercier, R., Li, C., Goutopoulos, A., Makriyannis, A., & Piomelli, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400997101 · Cited by 230
New perspectives on enigmatic vanilloid receptors
Szallasi, A., & Di Marzo, V. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01630-1 · Cited by 216
The fatty acid amide hydrolase (FAAH)
Deutsch, D. G., Ueda, N., & Yamamoto, S. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0358 · Cited by 210
Boutaud, O., Aronoff, D. M., Richardson, J. H., Marnett, L. J., & Oates, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102588199 · Cited by 209
Attenuation of thermal nociception and hyperalgesia by VR1 blockers
García-Martínez, C., Humet, M., Planells-Cases, R., Gomis, A., Caprini, M., Viana, F., De la Peña, E., Sanchez-Baeza, F., Carbonell, T., De Felipe, C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022285899 · Cited by 190
Melck, D., Bisogno, T., De Petrocellis, L., Chuang, H.-H., Julius, D., Bifulco, M., & Di Marzo, V. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1105 · Cited by 188
Mechanism of Acetaminophen Inhibition of Cyclooxygenase Isoforms
Ouellet, M., & Percival, M. D. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2232 · Cited by 166
Vaz, Z. R., Filho, V. C., Yunes, R. A., et al. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20136-7 · Cited by 152
Patricelli, M. P., Lashuel, H. A., Giang, D. K., Kelly, J. W., & Cravatt, B. F. (1998) · Biochemistry · doi:10.1021/bi981733n · Cited by 150
Self-citationOxidative metabolism of anandamide
BURSTEIN, S. H., Rossetti, R. G., Yagen, B., & Zurier, R. B. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00053-8 · Cited by 145
Expression of vanilloid receptor TRPV1 in the rat trigeminal sensory nuclei
Bae, Y. C., Oh, J. M., Hwang, S. J., Shigenaga, Y., & Valtschanoff, J. G. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20272 · Cited by 132
A role for endocannabinoids in indomethacin-induced spinal antinociception
Gühring, H., Hamza, M., Sergejeva, M., Ateş, M., Kotalla, C., Ledent, C. A., & Brune, K. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02485-8 · Cited by 129
Nephrotoxicity of p-aminophenol, a metabolite of acetaminophen, in the Fischer 344 rat
Newton, J. F., Kuo, C.-H., Gemborys, M. W., Mudge, G. H., & Hook, J. B. (1982) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(82)90017-5 · Cited by 120
Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol)
Grèen, K., Drvota, V., & Vesterqvist, O. (1989) · Prostaglandins · doi:10.1016/0090-6980(89)90001-4 · Cited by 112
Pelissier, T., Alloui, A., Caussade, F., Dubray, C., Cloarec, A., Lavarenne, J., & Eschalier, A. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20101-x · Cited by 107
Modification of anti-inflammatory drug effectiveness by ambient lipid peroxides
Hanel, A. M., & Lands, W. E. M. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90565-2 · Cited by 95
Possible mechanisms of cannabinoid-induced antinociception in the spinal cord
Morisset, V., Ahluwalia, J. P., Nagy, I., & Urbán, L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01309-7 · Cited by 87
Vanilloids. 1. Analogs of capsaicin with antinociceptive and antiinflammatory activity
Janusz, J. M., Buckwalter, B. L., Young, P. A., LaHann, T. R., Farmer, R. W., Kasting, G. B., Loomans, M. E., Kerckaert, G. A., & Maddin, C. S. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00070a002 · Cited by 78
In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue
Urbán, L., Campbell, E. A., Panesar, M., Patel, S., Chaudhry, N., Kane, S., Buchheit, K., Sandells, B., & James, I. F. (2000) · Pain · doi:10.1016/s0304-3959(00)00349-3 · Cited by 73
Phenacetin, acetaminophen and dipyrone: analgesic and rewarding effects
Abbott, F. V., & Hellemans, K. G. C. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00179-0 · Cited by 72
Ibuprofen Inhibits the Metabolism of the Endogenous Cannabimimetic Agent Anandamide
Fowler, C. J., Stenström, A., & Tiger, G. (1997) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1997.tb00291.x · Cited by 55
The effect of acetaminophen on prostacyclin production in pregnant women
O’Brien, W. F., Krammer, J., O'Leary, T., & Mastrogiannis, D. S. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90362-m · Cited by 39
Suh, Y., Lee, Y., Min, K., Park, O.-H., Seung, H.-S., Kim, H., Park, H.-G., Choi, J., Lee, J., Kang, S., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.024 · Cited by 38
Price, T. J., Patwardhan, A. M., Flores, C. M., & Hargreaves, K. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.031 · Cited by 35
Rodella, L. F., Borsani, E., Rezzani, R., Ricci, F., Buffoli, B., & Bianchi, R. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.12.031 · Cited by 32
Acetaminophen and upper gastrointestinal complications.
Werner, M. U., Nielsen, P. R., Rømsing, J., et al. (2002) · PubMed · doi:10.1097/01.ede.0000022255.63203.bb · Cited by 7
Acetaminophen and Upper Gastrointestinal Complications
Werner, M. U., Nielsen, P. R., & Rømsing, J. (2002) · Epidemiology · doi:10.1097/00001648-200209000-00023 · Cited by 7
Research works printed but not linked: 5
- Pelissier, 1996, J. Pharmacol. Exp. Ther., 278, 8
- Szallasi, 1999, Pharmacol. Rev., 51, 159
- Bisogno, 2000, Biochem. J., 351, 817, 10.1042/bj3510817 · doi:10.1042/bj3510817 · Paper page
- Vaz, 1996, J. Pharmacol. Exp. Ther., 278, 304
- Wahl, 2001, Mol. Pharmacol., 59, 9, 10.1124/mol.59.1.9 · doi:10.1124/mol.59.1.9 · Paper page
Cited by
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Targeting the endocannabinoid system: to enhance or reduce?
Di Marzo, V. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798
Paracetamol: New Vistas of an Old Drug
Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00250.x · Cited by 674
Graham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0172-x · Cited by 671
Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update
Siracusa, R., Paola, R. D., Cuzzocrea, S., & Impellizzeri, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083891 · Cited by 659
Metadata
- Authors
- Högestätt, E. D., Jönsson, B. A. G., Ermund, A., Andersson, D. A., Björk, H., Alexander, J. P., Cravatt, B. F., Basbaum, A. I., & Zygmunt, P. M.
- Affiliations
- Lund University (SE)
- Scripps Research Institute (US)
- University of California, San Francisco (US)
- Corresponding author
- Zygmunt, Peter M.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 280
- Issue
- 36
- Pages
- 31405-31412
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1977748966
- Cited by
- 454
- References
- 53
- Citations by year
- 2026: 14 · 2025: 20 · 2024: 18 · 2023: 36 · 2022: 17 · 2021: 24 · 2020: 23 · 2019: 15 · 2018: 24 · 2017: 27 · 2016: 15 · 2015: 22 · 2014: 27 · 2013: 24 · 2012: 25
- FWCI
- 12.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5537 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Vetenskapsrådet
- National Institutes of Health
- National Institute of Dental and Craniofacial Research (DE08377)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- paracetamol, AM404, fatty acid amide hydrolase, TRPV1 agonists, cyclooxygenase inhibition, endocannabinoid system, drug metabolism, analgesia, thermoregulation, prostaglandin synthesis, macrophages, brain, spinal cord
- MeSH terms
- Acetaminophen, Fatty Acid Amide Hydrolases, Amidohydrolases, Aminophenols, Animals, Arachidonic Acids, Brain, Cell Line, Central Nervous System, Female, Ganglia, Spinal, Macrophages, Membrane Proteins, Prostaglandin-Endoperoxide Synthases, Dinoprostone, Arachidonic Acid, Rats, Wistar, Mice, Knockout, Mice, Rats, Cyclooxygenase 1, Cyclooxygenase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.